Medicus Pharma Ltd. (MDCX) Insider Trading Disclosures
Medicus Pharma Ltd. (MDCX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MDCX
CIK: 1997296
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: A6
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerLewis Bird
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 424B3 | 2026-10-16 | — | FORM 424B3 | 0001062993-26-005385 | View SEC Doc Filr Page |
| 8-K | 2026-10-16 | 2026-10-12 | FORM 8-K | 0001062993-26-005382 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-16 | — | SCHEDULE 13G/A Filing | 0000950142-26-002781 | View SEC Doc Filr Page |
| 424B3 | 2026-10-07 | — | FORM 424B3 | 0001062993-26-005229 | View SEC Doc Filr Page |
| 8-K | 2026-10-07 | 2026-10-07 | FORM 8-K | 0001062993-26-005226 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-14 | — | SCHEDULE 13D Filing | 0000950142-26-002546 | View SEC Doc Filr Page |
| 424B3 | 2026-09-14 | — | FORM 424B3 | 0001062993-26-004910 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-11 | FORM 8-K | 0001062993-26-004906 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-04 | FORM 8-K | 0001062993-26-004898 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | OWNERSHIP DOCUMENT | 0000950142-26-002522 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | OWNERSHIP DOCUMENT | 0000950142-26-002521 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | OWNERSHIP DOCUMENT | 0000950142-26-002520 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | OWNERSHIP DOCUMENT | 0000950142-26-002519 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | OWNERSHIP DOCUMENT | 0000950142-26-002518 | View SEC Doc Filr Page |
| 424B3 | 2026-09-03 | — | FORM 424B3 | 0001062993-26-004809 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-02 | FORM 8-K | 0001062993-26-004806 | View SEC Doc Filr Page |
| 424B3 | 2026-08-13 | — | FORM 424B3 | 0001062993-26-004233 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | FORM 10-Q | 0001062993-26-004230 | View SEC Doc Filr Page |
| 424B3 | 2026-06-04 | — | FORM 424B3 | 0001062993-26-003064 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | FORM 8-K | 0001062993-26-003060 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | OWNERSHIP DOCUMENT | 0000950142-26-001643 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | OWNERSHIP DOCUMENT | 0000950142-26-001642 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | OWNERSHIP DOCUMENT | 0000950142-26-001641 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | OWNERSHIP DOCUMENT | 0000950142-26-001640 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | OWNERSHIP DOCUMENT | 0000950142-26-001639 | View SEC Doc Filr Page |